Holdings

中国远大集团有限责任公司

As of May 15, 2026, 中国远大集团有限责任公司 reported 2 positions. Largest: Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. Class H and Qyuns Therapeutics Co., Ltd. Class H. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. Class H42.1Mfirst reportMay 15, 2026
Qyuns Therapeutics Co., Ltd. Class H37.9Mfirst reportAug 25, 2025